易瑞生物(300942) - 2025年3月7日投资者关系活动记录表

Group 1: Company Development Strategy - The company will focus on developing food safety rapid testing and animal diagnosis businesses, with a strategic plan for 2025 that includes platform integration, intelligent management, international expansion, and corporate strategy [3][4]. - The international market is viewed as a significant growth area, with plans to enhance product quality and service recognition globally, particularly in sectors like dairy, pesticide residues, and microbiological testing [4]. Group 2: Core Business Composition - The main business activities include the sale of rapid testing reagents, instruments, and related testing services in the food safety and animal diagnosis sectors [4][5]. Group 3: Competitive Advantages - The company leads in core raw material R&D, offering a comprehensive range of testing solutions across the entire food safety chain, ensuring quality from source to end [5][6]. - The company has participated in the formulation of over 60 national and industry standards, enhancing its understanding of industry trends and improving its market responsiveness [5][6]. Group 4: Microbiological Testing Innovations - The company has developed various new products for microbiological testing, which can be applied in food safety, environmental monitoring, and biomedicine, indicating a broad market potential [7][8]. - The rapid microbiological testing technology reduces the total testing time to approximately 18-24 hours, significantly faster than traditional methods that take about 3-5 days [8]. Group 5: Market Demand for Rapid Testing - The primary demand for rapid testing services comes from government regulatory bodies and enterprises, driven by the need for efficiency and cost control in food safety [8].